JD.Com Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? JD.Com Inc trades at $26.93 (market cap $36.62B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B). The key difference: JD.Com Inc is the larger of the two by market cap, and JD.Com Inc pays a 3.72% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold JD.Com Inc for 85 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| JD | ROIV | |
|---|---|---|
Market Cap | $36.62B | $24.72B |
Volume | 6,571,477 | 6,279,442 |
Sector | Consumer Cyclical | Health |
52-Week High | $34.53 | $41.81 |
52-Week Low | $25.19 | $16.04 |
Typical Hold Time | 85 Days | 0 Days |
Enterprise Value | $19.26B | $20.99B |
Dividend Yield | 3.72% | — |
Signals from Pluang's Aura AI — not financial advice
JD.com is trading at $27.03, up 2.0% today, with strong analyst support showing 32 buy ratings versus just 1 sell. The stock demonstrates solid fundamentals with a low P/E of 17.98 and P/S of 0.2, trading below its $35.86 consensus price target. Recent earnings have consistently beaten expectations, though revenue growth has slowed in 2025 with net income margin declining to 1.13%. The company maintains a robust balance sheet with $234 billion in cash and is pursuing strategic acquisitions including the pending Ceconomy deal.
JD.com presents a compelling value opportunity with significant upside potential to analyst targets, supported by strong cash flow generation and consistent earnings beats. However, investors face risks from slowing revenue growth, regulatory scrutiny of international expansion, and competitive pressures in the Chinese e-commerce sector. The stock's current valuation appears attractive relative to peers, but requires monitoring of execution on strategic initiatives.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →